Marrone Bio Innov (MBII) 0.80 $MBII
Marrone Bio Innovation CEO and Founder, Pamela Marrone, Elected by Cornell Alumni to the Board of Trustees
BusinessWire - Tue Jun 07, 7:30AM CDT
Cornell University alumni have elected Pamela Marrone, Class of 1978 to the Cornell University Board of Trustees for a four-year term.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Receives Waiver Of $15 Million Minimum Cash Requirement
BusinessWire - Thu Jun 02, 7:30AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced that it has obtained a waiver from the lenders of its $40 million senior secured promissory notes, dated August 20, 2015, terminating the requirement that the Company maintain a $15 million minimum cash balance.
MBII: 0.80 (+0.06)
Koch Agronomic Services and Marrone Bio Innovations Agree to Exclusive Row Crop Sales Rights for Regalia Brands
BusinessWire - Wed Jun 01, 3:05PM CDT
Koch Agronomic Services, LLC (Koch), with support from its affiliate, Koch Biological Solutions, LLC, has secured exclusive rights to sell REGALIA(R) Rx in the U.S. and REGALIA(R) Maxx in Canada. Koch will market and sell the products for broad-acre agriculture applications. REGALIA(R) Rx and REGALIA(R) Maxx are manufactured by Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) and improve crop performance by providing defense against fungal pests. Both products also offer significant plant health benefits.
MBII: 0.80 (+0.06)
Zachary S. Wochok, Ph.D. Joins Marrone Bio Innovations' Board of Directors
BusinessWire - Tue May 31, 7:30AM CDT
Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI) today announced that at its annual meeting of stockholders on Wednesday, May 25, 2016, agribusiness, biotechnology and food industry executive Zachary S. Wochok, Ph.D., was newly elected to the company's Board of Directors. MBI's stockholders also reelected the Board's financial expert, George H. Kerckhove.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Agreement to Settle Class Action Litigation
BusinessWire - Thu May 26, 3:05PM CDT
Marrone Bio Innovations, Inc. (the "Company"
(NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the Company and other defendants, including certain of the Company's current and former officers and directors, have reached an agreement to settle the private securities class action litigation consolidated in the U.S. District Court for the Eastern District of California on February 13, 2015 as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. The agreement is subject to review and approval by the court after notice and an opportunity to object are provided to the plaintiff class. The settlement agreement contains no admission or concession of wrongdoing or liability by the Company or any other defendant and includes a full release of claims. The agreement provides for a settlement payment to the class of $12,000,000, which will be paid by insurance carriers. Accordingly, the settlement of these lawsuits will have no adverse impact on the Company's financial position or operations.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Sponsors Webinar: Arthropod Pests of Strawberries and Their Management
GlobeNewswire - Tue May 24, 8:53PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced an upcoming Webinar presenting an overview of arthropod pests of strawberries, to include identification, life cycles, scouting techniques, thresholds, conventional and biopesticide treatment options, as well as the importance of resistance management. The Webinar, presented by Agrian and sponsored by MBI, will be taught by Surendra Dara, Ph.D., University of California San Luis Obispo Cooperate Extension, covering both Santa Barbara and Ventura Counties.
MBII: 0.80 (+0.06)
Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
GlobeNewswire - Mon May 16, 6:00AM CDT
Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for food, feed and fuel, and Marrone Bio Innovations Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products, announced today that they have successfully met an important milestone in their multi-year collaboration focused on discovery and validation of novel genes for insect control. In diet-based insect assays, certain proteins demonstrated control activity against several target pest insects, including fall armyworm, a devastating pest that causes annual damage of approximately $1 billion worldwide. Based on these results, selected bioactive proteins are now being advanced by the two companies to plant validation.
MBII: 0.80 (+0.06), EVGN: 6.69 (-0.05)
Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
BusinessWire - Thu May 12, 3:05PM CDT
--First Quarter Product Shipments Increased 79% to $3.9 million
MBII: 0.80 (+0.06)
United States Environmental Protection Agency Approves Funding To Assess Open Water Application Techniques with Zequanox(R)
GlobeNewswire - Mon May 09, 10:40AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced that the United States Environmental Protection Agency has approved funding, under the Great Lakes Restoration Initiative (GLRI), to assess new, non-enclosed open water application techniques with Zequanox that Cameron Davis, Senior Advisor to the U.S. EPA Administrator, notes "potentially could expand invasive zebra and quagga mussel control possibilities throughout the Great Lakes Basin."
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Date for First Quarter 2016 Financial Results
BusinessWire - Mon May 09, 7:30AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced today that it will release its earnings results for the first quarter ended March 31, 2016 on Thursday, May 12, 2016 after the market closes.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Sponsors Webinar on "Diseases of Leafy Greens and Their Management"
GlobeNewswire - Thu May 05, 10:38AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced an upcoming Webinar presenting an overview of the diseases of leafy greens to include disease diagnosis, biology, life cycles, disease management, and discussion of conventional and organic control strategies. The Webinar, presented by Agrian, will be taught by Dr. Steven Koike of the University of California Cooperative Extension Service of Monterey.
MBII: 0.80 (+0.06)
Marrone Bio Adds Sales/Product Development Professional in Upper Midwest
GlobeNewswire - Thu Apr 21, 7:03AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announces the addition of Brian Mueller to its professional sales and product development team. A Sales Manager for Specialty Crops - Michigan and Northern Ohio Divisions - for Crop Production Services (CPS), Brian's experience in the channel distribution network brings an insightful perspective to MBI's growing team.
MBII: 0.80 (+0.06)
Marrone Bio Expands Reach, Growing Sales Team in Florida and Pacific Northwest
GlobeNewswire - Tue Apr 05, 12:43PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) today announces the addition of three sales professionals.
MBII: 0.80 (+0.06)
Marrone Bio Innovations, Inc. Reports 2015 Fourth Quarter and Full Year Results
BusinessWire - Wed Mar 30, 3:05PM CDT
--Increased Deferred Revenue Also Reflects Improved Shipping Activity and Execution Compared to Prior Year
MBII: 0.80 (+0.06)
Dr. Kathleen A. Merrigan Joins Board of Directors
BusinessWire - Thu Mar 24, 7:45AM CDT
Today, Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) announced the appointment of former United States Deputy Secretary of Agriculture Kathleen A. Merrigan, Ph.D., to its board of directors.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Date for Fourth Quarter and Full Year 2015 Financial Results
BusinessWire - Wed Mar 23, 3:40PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that it will release its earnings results for the fourth quarter and full year ended December 31, 2015 on Wednesday, March 30, 2016 after the market closes.
MBII: 0.80 (+0.06)
DigiPath Inc. (DIGP) Looks to Solve the Cannabis Industry's 'Dirty Little Secret'
ACCESSWIRE - Tue Mar 15, 9:20AM CDT
SEATTLE, WA / ACCESSWIRE / March 15, 2016 / A recent New York Post article titled "The marijuana industry has a dirty little secret" highlighted the growing problem of pesticides and other contaminants after a string of recently recalled products that were found to be contaminated. The problem is partially due to the haste of creating capacity following the legalization in Colorado, although the state government does share some of the blame for failing to implement effective regulations when initially setting up the program.
MBII: 0.80 (+0.06), SMG: 68.79 (unch)
Marrone Bio Innovations to Distribute Isagro's Bio-Tam 2.0 in U.S. West
PR Newswire - Thu Mar 10, 1:37PM CST
Marrone Bio Innovations, Inc. (NASDAQ: MBII) and Isagro USA, Inc (Isagro) are pleased to announce a distribution agreement under which Marrone Bio will distribute the Isagro Trichoderma based biofungicide to agricultural crop markets in California, Oregon, Washington and Arizona under the Bio-Tam® 2.0 brand.
MBII: 0.80 (+0.06)
Marrone Bio Innovations submits MBI-110 to EPA for regulatory review for controlling downy mildews and white molds
M2 - Wed Feb 10, 7:46AM CST
Biological products company Marrone Bio Innovations (NasdaqGM:MBII) reported on Tuesday that it has submitted a new biological fungicide (MBI-110) to the US Environmental Protection Agency for a new solutions for downy mildew.
MBII: 0.80 (+0.06)
Marrone Bio Innovation CEO and Founder, Pamela Marrone, Elected by Cornell Alumni to the Board of Trustees
BusinessWire - Tue Jun 07, 7:30AM CDT
Cornell University alumni have elected Pamela Marrone, Class of 1978 to the Cornell University Board of Trustees for a four-year term.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Receives Waiver Of $15 Million Minimum Cash Requirement
BusinessWire - Thu Jun 02, 7:30AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced that it has obtained a waiver from the lenders of its $40 million senior secured promissory notes, dated August 20, 2015, terminating the requirement that the Company maintain a $15 million minimum cash balance.
MBII: 0.80 (+0.06)
Koch Agronomic Services and Marrone Bio Innovations Agree to Exclusive Row Crop Sales Rights for Regalia Brands
BusinessWire - Wed Jun 01, 3:05PM CDT
Koch Agronomic Services, LLC (Koch), with support from its affiliate, Koch Biological Solutions, LLC, has secured exclusive rights to sell REGALIA(R) Rx in the U.S. and REGALIA(R) Maxx in Canada. Koch will market and sell the products for broad-acre agriculture applications. REGALIA(R) Rx and REGALIA(R) Maxx are manufactured by Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) and improve crop performance by providing defense against fungal pests. Both products also offer significant plant health benefits.
MBII: 0.80 (+0.06)
Zachary S. Wochok, Ph.D. Joins Marrone Bio Innovations' Board of Directors
BusinessWire - Tue May 31, 7:30AM CDT
Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI) today announced that at its annual meeting of stockholders on Wednesday, May 25, 2016, agribusiness, biotechnology and food industry executive Zachary S. Wochok, Ph.D., was newly elected to the company's Board of Directors. MBI's stockholders also reelected the Board's financial expert, George H. Kerckhove.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Agreement to Settle Class Action Litigation
BusinessWire - Thu May 26, 3:05PM CDT
Marrone Bio Innovations, Inc. (the "Company"
(NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the Company and other defendants, including certain of the Company's current and former officers and directors, have reached an agreement to settle the private securities class action litigation consolidated in the U.S. District Court for the Eastern District of California on February 13, 2015 as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. The agreement is subject to review and approval by the court after notice and an opportunity to object are provided to the plaintiff class. The settlement agreement contains no admission or concession of wrongdoing or liability by the Company or any other defendant and includes a full release of claims. The agreement provides for a settlement payment to the class of $12,000,000, which will be paid by insurance carriers. Accordingly, the settlement of these lawsuits will have no adverse impact on the Company's financial position or operations. MBII: 0.80 (+0.06)
Marrone Bio Innovations Sponsors Webinar: Arthropod Pests of Strawberries and Their Management
GlobeNewswire - Tue May 24, 8:53PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced an upcoming Webinar presenting an overview of arthropod pests of strawberries, to include identification, life cycles, scouting techniques, thresholds, conventional and biopesticide treatment options, as well as the importance of resistance management. The Webinar, presented by Agrian and sponsored by MBI, will be taught by Surendra Dara, Ph.D., University of California San Luis Obispo Cooperate Extension, covering both Santa Barbara and Ventura Counties.
MBII: 0.80 (+0.06)
Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
GlobeNewswire - Mon May 16, 6:00AM CDT
Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for food, feed and fuel, and Marrone Bio Innovations Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products, announced today that they have successfully met an important milestone in their multi-year collaboration focused on discovery and validation of novel genes for insect control. In diet-based insect assays, certain proteins demonstrated control activity against several target pest insects, including fall armyworm, a devastating pest that causes annual damage of approximately $1 billion worldwide. Based on these results, selected bioactive proteins are now being advanced by the two companies to plant validation.
MBII: 0.80 (+0.06), EVGN: 6.69 (-0.05)
Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
BusinessWire - Thu May 12, 3:05PM CDT
--First Quarter Product Shipments Increased 79% to $3.9 million
MBII: 0.80 (+0.06)
United States Environmental Protection Agency Approves Funding To Assess Open Water Application Techniques with Zequanox(R)
GlobeNewswire - Mon May 09, 10:40AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced that the United States Environmental Protection Agency has approved funding, under the Great Lakes Restoration Initiative (GLRI), to assess new, non-enclosed open water application techniques with Zequanox that Cameron Davis, Senior Advisor to the U.S. EPA Administrator, notes "potentially could expand invasive zebra and quagga mussel control possibilities throughout the Great Lakes Basin."
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Date for First Quarter 2016 Financial Results
BusinessWire - Mon May 09, 7:30AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced today that it will release its earnings results for the first quarter ended March 31, 2016 on Thursday, May 12, 2016 after the market closes.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Sponsors Webinar on "Diseases of Leafy Greens and Their Management"
GlobeNewswire - Thu May 05, 10:38AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announced an upcoming Webinar presenting an overview of the diseases of leafy greens to include disease diagnosis, biology, life cycles, disease management, and discussion of conventional and organic control strategies. The Webinar, presented by Agrian, will be taught by Dr. Steven Koike of the University of California Cooperative Extension Service of Monterey.
MBII: 0.80 (+0.06)
Marrone Bio Adds Sales/Product Development Professional in Upper Midwest
GlobeNewswire - Thu Apr 21, 7:03AM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) today announces the addition of Brian Mueller to its professional sales and product development team. A Sales Manager for Specialty Crops - Michigan and Northern Ohio Divisions - for Crop Production Services (CPS), Brian's experience in the channel distribution network brings an insightful perspective to MBI's growing team.
MBII: 0.80 (+0.06)
Marrone Bio Expands Reach, Growing Sales Team in Florida and Pacific Northwest
GlobeNewswire - Tue Apr 05, 12:43PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII) today announces the addition of three sales professionals.
MBII: 0.80 (+0.06)
Marrone Bio Innovations, Inc. Reports 2015 Fourth Quarter and Full Year Results
BusinessWire - Wed Mar 30, 3:05PM CDT
--Increased Deferred Revenue Also Reflects Improved Shipping Activity and Execution Compared to Prior Year
MBII: 0.80 (+0.06)
Dr. Kathleen A. Merrigan Joins Board of Directors
BusinessWire - Thu Mar 24, 7:45AM CDT
Today, Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) announced the appointment of former United States Deputy Secretary of Agriculture Kathleen A. Merrigan, Ph.D., to its board of directors.
MBII: 0.80 (+0.06)
Marrone Bio Innovations Announces Date for Fourth Quarter and Full Year 2015 Financial Results
BusinessWire - Wed Mar 23, 3:40PM CDT
Marrone Bio Innovations, Inc. (NASDAQ:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that it will release its earnings results for the fourth quarter and full year ended December 31, 2015 on Wednesday, March 30, 2016 after the market closes.
MBII: 0.80 (+0.06)
DigiPath Inc. (DIGP) Looks to Solve the Cannabis Industry's 'Dirty Little Secret'
ACCESSWIRE - Tue Mar 15, 9:20AM CDT
SEATTLE, WA / ACCESSWIRE / March 15, 2016 / A recent New York Post article titled "The marijuana industry has a dirty little secret" highlighted the growing problem of pesticides and other contaminants after a string of recently recalled products that were found to be contaminated. The problem is partially due to the haste of creating capacity following the legalization in Colorado, although the state government does share some of the blame for failing to implement effective regulations when initially setting up the program.
MBII: 0.80 (+0.06), SMG: 68.79 (unch)
Marrone Bio Innovations to Distribute Isagro's Bio-Tam 2.0 in U.S. West
PR Newswire - Thu Mar 10, 1:37PM CST
Marrone Bio Innovations, Inc. (NASDAQ: MBII) and Isagro USA, Inc (Isagro) are pleased to announce a distribution agreement under which Marrone Bio will distribute the Isagro Trichoderma based biofungicide to agricultural crop markets in California, Oregon, Washington and Arizona under the Bio-Tam® 2.0 brand.
MBII: 0.80 (+0.06)
Marrone Bio Innovations submits MBI-110 to EPA for regulatory review for controlling downy mildews and white molds
M2 - Wed Feb 10, 7:46AM CST
Biological products company Marrone Bio Innovations (NasdaqGM:MBII) reported on Tuesday that it has submitted a new biological fungicide (MBI-110) to the US Environmental Protection Agency for a new solutions for downy mildew.
MBII: 0.80 (+0.06)
